Trelagliptin succinate 是一种有效的，具有口服活性的DPP-4抑制剂，IC50=4 nM。它可以改善体内血糖控制，能够用于2 型糖尿病 (T2DM) 的研究。

Trelagliptin(SYR-472) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), being developed for the treatment of type 2 diabetes (T2D).

1029877-94-8

C22H26FN5O6

475.47

SYR472;曲格列汀琥珀酸盐;琥珀酸曲格列汀;SYR-472 succinate

DMSO:10 mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years